Log in to save to my catalogue

Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line...

Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8885415

Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysis

About this item

Full title

Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysis

Publisher

London: Nature Publishing Group UK

Journal title

Leukemia, 2022-03, Vol.36 (3), p.772-780

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

To evaluate patterns of rrHL after contemporary first-line treatment we studied 409 patients with first rrHL (HD13:
n
 = 87, HD14:
n
 = 118, HD15:
n
 = 188, HDR3i:
n
 = 51) at a median age of 37.4 years (18.4–76.8) from the GHSG database. Time to first relapse was ≤12 months in 49% and stage III/IV rrHL present in 52% of pat...

Alternative Titles

Full title

Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8885415

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8885415

Other Identifiers

ISSN

0887-6924,1476-5551

E-ISSN

1476-5551

DOI

10.1038/s41375-021-01442-8

How to access this item